An MHC-restricted antibody-based chimeric antigen receptor requires TCR-like affinity to maintain antigen specificity.

Maus, Marcela V; Plotkin, Jason; Jakka, Gopinadh; Stewart-Jones, Guillaume; Rivière, Isabelle; Merghoub, Taha; Wolchok, Jedd; Renner, Christoph; Sadelain, Michel

Maus, Marcela V; Plotkin, Jason; Jakka, Gopinadh; Stewart-Jones, Guillaume; Rivière, Isabelle; Merghoub, Taha; Wolchok, Jedd; Renner, Christoph; Sadelain, Michel.

Afiliación

Maus MV; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Plotkin J; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Jakka G; Department of Oncology, University Hospital Zurich, Zurich, Switzerland.
Stewart-Jones G; Division of Structural Biology, Welcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
Rivière I; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Merghoub T; Ludwig Center for Cancer Immunotherapy, Swim Across America Laboratory, MSKCC, New York, New York, USA.
Wolchok J; Ludwig Center for Cancer Immunotherapy, Swim Across America Laboratory, MSKCC, New York, New York, USA.
Renner C; Department of Oncology, University Hospital Zurich, Zurich, Switzerland.
Sadelain M; Department of Oncology, University Hospital Basel, Basel, Switzerland.

Mol Ther Oncolytics ; 3: 1-9, 2016.

Article en En | MEDLINE | ID: mdl-29675462

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Ther Oncolytics Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google